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Abstract 
BACKGROUND: Distinguishing between Acute Coronary Syndrom (ACS) and SCAD (Stable Coronary Artery 
Disease) requires advanced laboratory instrument and electrocardiogram. However, their availabilities in primary 
care settings in developing countries are limited. Hematologic changes usually occur in the ACS patient and might 
be valuable to distinguish ACS from SCAD.  
AIM: This study compares the hematologic indices between ACS and SCAD patients and analyses its predictive 
value for ACS. 
MATERIAL AND METHODS: A total of 191 patients (79 ACS and 112 SCAD) were enrolled in this study based 
on the inclusion criteria. Patient’s characteristic, hematologic indices on admission, and the final diagnosis were 
obtained from medical records. Statistical analyses were done using SPSS 23.0. 
RESULTS: In this research MCHC value (33.40 vs. 32.80 g/dL; p < 0.05); WBC (11.16 vs. 7.40 x109/L; p < 
0.001); NLR (6.29 vs. 2.18; p < 0.001); and PLR (173.88 vs 122.46; p < 0.001) were significantly higher in ACS 
compared to SCAD patients. While MPV (6.40 vs. 10.00 fL; p < 0.001) was significantly lower in ACS patients. 
ROC curve analysis showed MPV had the highest AUC (95%) for ACS diagnosis with an optimum cut-off point at 
≤ 8.35 fL (sensitivity 93.6% and specificity 97.3%). 
CONCLUSION: There was a significant difference between hematologic indices between ACS and SCAD 
patients. MPV is the best indices to distinguish ACS. 
 
 
 
 
Introduction 
 
Coronary Artery Disease (CAD) is the leading 
cause of death worldwide, including Indonesia. WHO 
reported that CAD caused 138.400 deaths of 
Indonesian in 2012 [1]. Most of CAD is caused by 
coronary artery narrowing from atherosclerosis [2]. 
The characteristics of atherosclerosis determine the 
clinical manifestation of CAD. Vulnerable plaque or 
unstable plaque will result in atherothrombosis event 
which is the hallmark of Acute Coronary Syndrome 
(ACS), while stable plaque consists of poor-lipid core 
and thick fibrous cap will be manifested as Stable 
Coronary Artery Disease (SCAD) [2], [3], [4]. 
Rapid coronary revascularisation is beneficial 
for ACS patients to reduce adverse events or death 
[5]. Therefore, early diagnosis of ACS is critical since 
mortality rates in the ACS patients are up to seven 
times higher than SCAD [6]. However, due to the 
limited availability of the electrocardiogram (ECG) and 
cardiac markers in the primary care setting, diagnosis 
of the ACS may become a big challenge for primary 
care physician in developing countries [7]. The 
previous study even showed that the availability of 
ECG in the rural primary care setting was only 63.3% 
[8]. Hence, easy and accessible screening approach 
for diagnosis of ACS in primary care settings is 
urgently needed. 
Pathogenesis of atherosclerosis is related to 
the inflammation and hematologic responses. Various 
inflammatory substance and hematologic cells are 
involved in the pathogenesis of atherosclerotic lesion 
[9], [10], [11]. Leukocyte and platelets play major roles 
in the foam cell generation, cytokines secretion, 
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including Reactive Oxygen Species (ROS), and 
cardiomyocytes death, which contribute to the 
atherosclerosis progression [12]. The lesion in ACS 
exhibits acute condition and activates neutrophil as 
pro-inflammatory cells [4], [13]. ACS also usually 
followed by inflammation regulation by anti-
inflammatory cells such as lymphocyte cells [14], [15]. 
Platelets also play a role in the ACS by inducing 
higher inflammatory activity and thrombogenicity [3], 
[4], [16]. Contrary, the lesion in SCAD exhibits chronic 
and lower grade of inflammation compared to ACS. 
Previous studies showed that white blood cell count 
and inflammatory markers are significantly higher in 
the ACS group compared to SCAD [9], [10], [11]. 
However, the comparison of other hematologic indices 
between ACS and SCAD is yet to be investigated.  
Thus, this study compares hematologic 
indices between ACS and SCAD patients and analyse 
its predictive value to distinguish ACS. 
 
 
Material and Methods 
 
Study design, Sampling, and Participants 
This retrospective cross-sectional study was 
conducted in Dr Soetomo General Hospital, 
Surabaya, Indonesia. Total sampling was done from 
all medical records of the patient diagnosed with ACS 
or SCAD from January to December 2017. Patients 
with kidney and liver abnormalities, active infection, 
cancer, haematological diseases, corticosteroid 
therapy, and chemotherapy are excluded. Dr Soetomo 
General Hospital Surabaya Ethical Committee in 
Health Research has approved this study (approval 
number 0485/KEPK/VIII/2018). Privacy and 
confidentiality of the information were guaranteed, as 
data did not include patient personal identities 
 
Data Collection 
Age, Sex, CAD type (ACS or SCAD), 
erythrocyte indices (MCHC, Hgb, Hct), leukocytes 
indices (WBC, Neutrophil Percentage, Lymphocyte 
Percentage) and platelet indices (MPV, PLT) were 
obtained from medical records. Diagnosis of ACS is 
defined by ICD10 diagnosis code I20.0 as Unstable 
Angina Pectoris (UAP), I21.0 and I21.1 as ST-
Elevation Myocardial Infarction (STEMI), and I21.4 as 
Non-ST-Elevation Myocardial Infarction (NSTEMI). 
Diagnosis of SCAD is defined by ICD10 diagnosis 
code I25.0 with no history of ACS or myocardial 
infarction. Neutrophil to Lymphocyte Ratio (NLR) was 
calculated by dividing Neutrophil Percentage to 
Lymphocyte Percentage, while Platelet to Lymphocyte 
ratio (PLR) was calculated by dividing PLT to the 
multiplication of Lymphocyte Percentage with WBC.  
 
Statistical Analysis 
Statistical analyses were performed using 
SPSS Statistics 23.0. Continuous variables, presented 
as mean±SD, was compared using Independent T-
test or Mann Whitney test based on the normality test. 
Specificity and sensitivity were obtained from the ROC 
curve and cut-off point analysis. 
 
 
Results 
 
Baseline Characteristics 
Total of 191 medical records consisting of 79 
ACS patient (9 UAP, 10 NSTEMI, and 60 STEMI) and 
112 SCAD met the inclusion criteria and included in 
this study. In both groups, most of the participants 
were male and aged below sixty. There was no 
significant difference between the two groups (Table 
1). 
Table 1: Baseline characteristics of ACS and SCAD patients 
Variable 
ACS 
(n = 79) 
SCAD 
(n = 112) 
p-value 
Sex, n (%)   
0.741 Male 64 (81.0%) 94 (83.9%) 
Female 15 (19.0%) 18 (16.1%) 
Age (years) 56.82 ± 9.532 57.78 ± 9.300 0.490 
 
Comparison of Erythrocyte Indices 
This study focuses on comparing MCHC 
values between two groups, Hgb and Hct values are 
used to analyse the component of MCHC value since 
MCHC is the ratio between Hgb and Hct. MCHC 
values were significantly higher in ACS than SCAD (p 
= 0.019), while Hgb and Hct were not significantly 
different (Table 2). 
 
Comparison of Leukocyte Indices 
This study compares the WBC values 
between two groups: the percentage of Neutrophil and 
Lymphocyte values are used to calculate NLR and 
PLR value. WBC and percentage of Neutrophil were 
significantly higher, while the percentage of 
Lymphocyte was significantly lower in ACS than 
SCAD with all p-value less than 0.001, respectively 
(Table 2). 
Comparison of Platelet Indices 
This study compares the MPV values 
between two groups; PLT values are used to calculate 
PLR value. MPV was significantly lower in ACS than 
SCAD with p-value less than 0.001, while PLT was 
not significantly different (Table 2).  
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Comparison of Other Indices 
Both NLR and PLR values were significantly 
higher in ACS than SCAD with the p-value of less 
than 0.001 (Table 2). 
Table 2: Comparison of hematological indices between ACS 
and SCAD patients 
Indices 
ACS 
(n = 79) 
SCAD 
(n = 112) 
p-value 
Erythrocyte     
 Hgb (g/dL)1 13.94 ± 1.51 13.72 ± 1.41 0.303 
 Hct (%)1 41.79 ± 4.91 41.69 ± 4,04 0.877 
 MCHC (g/dL) 33.44 ± 1.85 32.92 ± 1.09 0.019* 
Leukocyte    
 WBC (x 109 /L) 11.72 ± 3.41 8.07 ± 5.31 < 0.001* 
 Neu% (%) 77.27 ± 11.03 59.94 ± 8.11 < 0.001* 
 Lymp% (%) 14.92 ± 8.51 27.58 ± 7.06 < 0.001* 
Platelet    
 PLT (x 109 /L)1 267.95 ± 75.57 257.91 ± 59.70 0.307 
 MPV (fL) 6.64 ± 1.29 10.04 ± 0.94 < 0.001* 
Other    
 NLR 7.45 ± 5.31 2.48 ± 1.58 < 0.001* 
 PLR 203.84 ± 111.72 136.38 ± 56.200 < 0.001* 
1Data were normally distributed; *P < 0.05 was considered statistically significant; Hgb = 
Hemoglobin; Hct = Hematocrit; MCHC = Mean Corpuscular Hemoglobin Concentration; WBC = 
White Blood Cells; Neu% = Percentage of Neutrophil; Lymp% = Percentage of Lymphocyte; PLT = 
Platelets; MPV = Mean Platelet Volume; NLR = Neutrophil to Lymphocyte Ratio; PLR = Platelet to 
Lymphocyte Ratio. 
 
Cut-off Point 
ROC Curve of MCHC, WBC, NLR, and PLR is 
set to indicate ACS if its value is increasing (Figure 
1A), while ROC Curve of MPV is set to indicate ACS if 
its value is decreasing (Figure 1B). MPV has highest 
AUC (95.0%) followed by WBC and NLR (88.4%), 
PLR (71.7%), and MCHC (60.0%) respectively (Table 
3). 
 
Figure 1: Receiving Operating Characteristics Curve of A) MCHC, 
WBC, NLR, and PLR; B) MPV 
 
The cut-off point for MPV to distinguish ACS 
was 8.35 fL with very high sensitivity (93.6%) and 
specificity (97.3%). This section may be divided by 
subheadings. It should provide a concise and precise 
description of the experimental results, their 
interpretation as well as the experimental conclusions 
that can be drawn. 
Table 3: ROC analysis and cut-off points for each index 
Indices 
AUC 
(%) 
95% CI 
Cut-Off 
Sensitivity 
(%) 
Specificity 
(%) 
Lower 
Bound 
Upper 
Bound 
MCHC 60.0 0.517 0.683 33.050 58.2 59.8 
WBC 88.4 0.835 0.933 9.170 81.0 80.4 
MPV 95.0 0.907 0.992 8.350 93.6 97.3 
NLR 88.4 0.828 0.939 3.187 81.0 85.7 
PLR 71.7 0.641 0.793 147.087 69.6 67.9 
 
 
Discussion 
 
To our knowledge, this is the first study 
comparing various haematological indices 
simultaneously between ACS and SCAD patient, 
especially in Indonesia. Baseline characteristics for 
both ACS and SCAD are similar, which dominated by 
male and majority aged below sixty. This result is 
relatively similar to the previous study in Makassar, 
Indonesia [17]. Southeast Asian countries indeed 
have younger morbidity and mortality due to non-
communicable disease, primarily cardiovascular 
disease compared to another region such as 
European. This difference may be due to a rapid 
epidemiological transition in Southeast Asian 
countries [17], [18]. 
Based on this study, MCHC value is 
significantly higher in the ACS group. This result is 
similar to previous studies, which showed MCHC 
value is significantly higher in CAD patients compared 
to healthy control [19], [20]. However, a study showed 
MCHC is lower in acute myocardial infarction 
compared to SCAD patients, yet it is not statistically 
significant (32.09 ± 1.34 vs 32.70 ± 1.45, p = 0.071) 
[20]. The previous theory stated there is a complex 
interaction between inflammation, iron metabolism, 
and anaemia, which affect MCHC value. During 
inflammation, the body will decrease iron serum levels 
by duodenal absorption and macrophage regulation 
[21]. Low iron serum levels will lead to iron-deficiency 
anaemia and decrease MCHC value [22]. Despite a 
few studies explaining these results; we hypothesise 
that high grade of inflammation in ACS leads to higher 
oxidative stress resulting in hemolysis and increasing 
MCHC value. Oxidative stress impairs erythrocyte 
metabolism and causes hemolysis [23]. Hemolysis will 
lead to increased haemoglobin production, followed 
by increased MCHC value as the ratio between 
haemoglobin and hematocrit. Other than a high grade 
of inflammation, risk factor such as smoking also 
contributes to oxidative stress [23]. Study in Indonesia 
has shown that ACS patients have a higher number of 
smoker compared to SCAD patient [17]. 
The result of WBC is similar to the previous 
study, which showed WBC of ACS patients is 
significantly higher compared to SCAD patients [10], 
[11]. Based on the previous study, WBC of ACS 
patients ranging from 7.07 ± 2.02 to 9.40 ± 3.30 x 
10
9
/L, while SCAD patients are ranging from 6.63 ± 
1.57 to 6.60 ± 1.40 x 10
9
/L [10], [11]. In this study, 
WBC for ACS is higher than the previous study (11.72 
± 3.41 x 10
9
/L) since the majority of participants in this 
study were STEMI patient (75.95%), while the 
previous study was UAP [10]. A study comparing 
WBC of STEMI and NSTEMI group showed higher 
WBC in the STEMI group (11.850 vs 8.460 x 10
9
/L, p 
= 0.01). Elevation of WBC is related to the complex 
and dynamic inflammation response in local and 
systemic level. Leukocyte has major role in 
Luke et al. Predictive Value of Hematologic Indices in the Diagnosis of Acute Coronary Syndrome 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Aug 15; 7(15):2428-2433.                                                                                                                                                2431 
 
pathogenesis and progression of the atherosclerotic 
lesion. Local low-grade inflammation during early 
lesion, endothelial dysfunction, and foam cell 
production is related to leukocytes activities [3]. 
Leukocytes activities are also responsible for plaque 
stability. During various atherosclerosis phases, there 
is continuous activation and infiltration of neutrophils 
resulting in plaque instability via myeloperoxidase 
(MPO) and metalloproteinase (MMP) release [13]. 
Myocardial damage from the atherosclerosis 
occlusion can also increase the neutrophil and 
macrophage numbers via cytokines, chemokine, and 
other substance stimulation [24].  
Previous studies showed that ACS patients 
have higher MPV compared to SCAD patients [25], 
[26], [27]. Higher MPV is correlated to various 
cardiovascular risks and higher thrombogenicity due 
to platelet metabolic and enzymatic activity [28], [29]. 
Interestingly, our study showed a different result, 
which showed that ACS patients had significantly 
lower MPV compared to SCAD patients. We 
hypothesise there was dynamic and complex platelet 
regulation during ACS, including production and 
consumption of platelet. During inflammation, larger 
platelet was produced. However, atherothrombotic 
lesion exhibits high consumption of large and 
hyperactive platelet [28].  
Furthermore, high-grade inflammation 
diseases such as rheumatoid arthritis and 
inflammatory bowel disease also showed lower MPV 
due to local active and large platelet consumption 
[28]. This theory is supported by the fact that activated 
platelet is six times more potent to adhere to 
polymorphonuclear cells and monocytes compared to 
inactive platelet [30]. Other theories suggest that 
during ACS, there is acute and general activation of 
platelet without followed by increased MPV [31]. 
In this research, both NLR and PLR are 
higher in ACS compared to SCAD. Similarly, the 
previous study showed NLR is elevated in both ACS 
and SCAD compared to healthy controls [32], [33], 
[34]. Higher NLR in ACS is related to acute and 
higher-grade inflammation response which neutrophils 
act as acute phase pro-inflammatory agents and 
lymphocytes as anti-inflammatory agents. Low 
lymphocyte level is likely due to the complex 
interaction between cytokines, neutrophils, and 
lymphocytes. ACS has the highest levels of circulating 
IFN-γ, followed by SCAD and healthy control [35]. 
Neutrophils activated IFN-γ suppresses lymphocyte 
proliferation through Programmed Death Ligand 1 
expression [36]. 
The previous study also showed PLR is 
elevated in both ACS and SCAD compared to healthy 
controls [32], [37], [38]. This study shows that 
elevated PLR is mainly due to lower lymphocyte 
count. Low lymphocyte count in ACS condition may 
be due to cortisol release or lymphocyte migration 
from blood circulation [37], [38]. Platelet count in ACS 
and SCAD showed inconsistent results, several 
studies showed platelet count is higher in ACS group 
compared to SCAD and healthy control [11], [39], 
while others showed lower platelet count [32], [40]. A 
study also showed platelet count in myocardial 
infarction patient is higher compared to healthy control 
but lower in unstable angina patient [41]. We 
hypothesise this inconsistency is due to the complex 
relation between thrombopoietin and regulation of 
platelet in inflammation settings. Thrombopoietin, a 
platelet production regulatory hormone, is elevated in 
unstable angina patient compared to SCAD and 
healthy control [42]. This elevation is due to platelet 
consumption during the acute myocardial attack to 
stimulate megakaryocytes proliferation [43]. Other 
theory suggested that interaction between 
thrombopoietin and its receptor on the platelet surface 
will decrease thrombopoietin, resulting in the low 
production of the platelet. Platelet with high MPV will 
have many receptors which induces inhibitory 
feedback resulted in lower platelet count [44]. 
This study analysed the cut-off point for five 
indices. MPV cut-off point was 8.35 fL, and lower MPV 
suggests a diagnosis of ACS. This result is different 
from the previous study, which showed MPV cut-off 
point was 9.15 fL or higher with sensitivity 72% and 
specificity 40% [25]. In this research, the cut-off point 
of NLR was 3.187, which higher NLR is suggestive for 
ACS diagnosis. The previous study showed that NLR 
above 2.5 could diagnose ACS with the sensitivity of 
63.6% and specificity 80.2% [32]. A meta-analysis 
also showed that NLR cut-off point from 1.95 to 3.97 
could predict severe atherosclerotic lesion [45]. In this 
research, WBC of more than 9.170 is suggestive for 
ACS diagnosis. Previously, WBC been reported to 
have a cut-off point of 6.91; 7.37; and 8.89 x 10
3
/μL 
with each sensitivity and specificity are 86% and 37%; 
45% and 54%; 54% and 71% respectively [46]. 
Overall, our study showed that MPV, NLR, and WBC 
is not inferior to other inflammation markers such as 
IL-6 to diagnose ACS. Previously, a study in 
Indonesia showed IL-6 with cut-off point 4.43 pg/mL 
can distinguish ACS and SCAD with sensitivity and 
specificity are 80.95% and 77.42%, respectively [9]. 
Benefits in Further Clinical Practice: 
Descriptions of chest pain from CAD patients are 
often subjective, dependent on communication skills, 
and different from Diamond and Forrester angina 
classification [47]. Moreover, the general practitioner 
ability to diagnose ACS and SCAD based on sign and 
symptom is considered low [48]. The complete blood 
count is a simple and accessible examination in the 
primary care setting. General practitioner with limited 
resources could consider MPV, NLR, and WBC to 
distinguish chest pain originated from ACS or SCAD. 
Strength and Limitations of the Study: To our 
knowledge, this is the first study comparing various 
haematological indices simultaneously between ACS 
and SCAD patient, especially in Indonesia. Moreover, 
this study also firstly showed the difference in MCHC, 
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NLR, and PLR value in ACS and SCAD group. 
However, this study may yet to be generalised since it 
only involved single-centre as the source of data. This 
study also used consecutive samplings from all 
patients who were admitted for ACS or SCAD 
diagnosis. Hence, selection bias might occur. In the 
future, it is suggested to involve more hospital and 
stratify the sample based on several risk factors such 
as race and social status to ensure the validity of the 
hematologic indices among various demographic 
characteristics. 
In conclusion, there was a significant 
difference in hematologic indices between ACS and 
SCAD patients. ACS had higher MCHC, WBC, NLR, 
PLR, and lower MPV compared to SCAD group. MPV 
had highest AUC (95.0%) with optimum cut-off point 
was 8.35 fL (sensitivity 93.6% and specificity 97.3%).  
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